The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …

Cancer is one of the leading causes of death worldwide. Several treatments are available for
cancer treatment, but many treatment methods are ineffective against multidrug-resistant …

Lung cancer causes the largest number of cancer-related deaths in the world. Most (85%) of
lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung …

Epigenetic dysregulation has emerged as an important mechanism in cancer. Alterations in
epigenetic machinery have become a major focus for targeted therapies. The current report …

Multi-drug resistance (MDR) has become the largest obstacle to the success of cancer
chemotherapies. The mechanisms of MDR and the approaches to test MDR have been …

Small‐cell lung cancer (SCLC) accounts for approximately 15% of lung cancer cases;
however, it is characterized by easy relapse and low survival rate, leading to one of the most …

Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer, accounting for
approximately 15% among all lung cancers. Despite the ability of chemotherapy, the first …

Lung cancer is the leading cause of cancer mortality worldwide. Despite advances in anti-
cancer therapies such as chemotherapy, radiotherapy and targeted therapies, five-year …

Green tea accounts for approximately 20% of the world's total tea yield.(−)-Epigallocatechin
gallate (EGCG) is an active catechin in green tea, which suppresses tumor growth and …

Background: Small cell lung carcinoma (SCLC) is an aggressive, recalcitrant cancer, often
metastatic at diagnosis and unresponsive to chemotherapy upon recurrence, thus it is …